Andersen A, Knop FK, Vilsbøll T. A pharmacological and clinical overview of oral semaglutide for the treatment of type 2 diabetes. Drugs. 2021;81(9):1003–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haddad F, Dokmak G, Bader M, Karaman R. A Comprehensive Review on Weight loss Associated with anti-diabetic medications. Life (Basel). 2023;13(4).

Sattar N, Lee MMY, Kristensen SL, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 2021;9(10):653–62.

Article  CAS  PubMed  Google Scholar 

Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221–32.

Article  CAS  PubMed  Google Scholar 

Ali MU, Mancini GBJ, Fitzpatrick-Lewis D, et al. The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis. Cardiovasc Diabetol. 2024;23(1):72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seferović PM, Coats AJS, Ponikowski P, et al. European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure. Eur J Heart Fail. 2020;22(2):196–213.

Article  PubMed  Google Scholar 

Villaschi A, Ferrante G, Cannata F, et al. GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis. Clin Res Cardiol. 2024;113(6):898–909.

Article  PubMed  Google Scholar 

Varbo A, Nordestgaard BG. Nonfasting triglycerides, Low-Density Lipoprotein Cholesterol, and heart failure risk: two cohort studies of 113 554 individuals. Arterioscler Thromb Vasc Biol. 2018;38(2):464–72.

Article  CAS  PubMed  Google Scholar 

Hage C, Löfgren L, Michopoulos F, et al. Metabolomic Profile in HFpEF vs HFrEF patients. J Card Fail. 2020;26(12):1050–9.

Article  PubMed  Google Scholar 

Yao H, Zhang A, Li D, et al. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis. BMJ. 2024;384:e076410.

Article  PubMed  PubMed Central  Google Scholar 

Kosiborod MN, Bhatta M, Davies M, et al. Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses. Diabetes Obes Metab. 2023;25(2):468–78.

Article  CAS  PubMed  Google Scholar 

Gallo G, Volpe M. Potential mechanisms of the Protective effects of the Cardiometabolic drugs Type-2 sodium-glucose transporter inhibitors and glucagon-like Peptide-1 receptor agonists in Heart failure. Int J Mol Sci 2024;25(5).

Jendle J, Hyötyläinen T, Orešič M, Nyström T. Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride. Cardiovasc Diabetol. 2021;20(1):237.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Emdin CA, Khera AV, Kathiresan S, Mendelian Randomization. JAMA. 2017;318(19):1925–6.

Article  PubMed  Google Scholar 

Larsson SC, Butterworth AS, Burgess S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J. 2023;44(47):4913–24.

Article  PubMed  PubMed Central  Google Scholar 

Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA. 2021;326(16):1614–21.

Article  PubMed  Google Scholar 

Xue A, Wu Y, Zhu Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941.

Article  PubMed  PubMed Central  Google Scholar 

Yengo L, Sidorenko J, Kemper KE, et al. Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry. Hum Mol Genet. 2018;27(20):3641–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willer CJ, Schmidt EM, Sengupta S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45(11):1274–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Richardson TG, Sanderson E, Palmer TM, et al. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable mendelian randomisation analysis. PLoS Med. 2020;17(3):e1003062.

Article  PubMed  PubMed Central  Google Scholar 

Shah S, Henry A, Roselli C, et al. Genome-wide association and mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun. 2020;11(1):163.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao B, Li T, Fan Z, et al. Heart-brain connections: phenotypic and genetic insights from magnetic resonance images. Science. 2023;380(6648):abn6598.

Article  CAS  PubMed  Google Scholar 

Sun Y, Liu Y, Dian Y, Zeng F, Deng G, Lei S. Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target mendelian randomization and clinical trials. Int J Surg. 2024.

Võsa U, Claringbould A, Westra H-J, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300–10.

Article  PubMed  PubMed Central  Google Scholar 

Stephen B, George DS, Neil MD, et al. Guidelines for performing mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2023;4:186.

Article  Google Scholar 

Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125(1–2):279–84.

Article  CAS  PubMed  Google Scholar 

Guo W, Zhao L, Huang W, et al. Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample mendelian randomization study. Cardiovasc Diabetol. 2024;23(1):118.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for mendelian randomization. Stat Methods Med Res. 2017;26(5):2333–55.

Article  PubMed  Google Scholar 

Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512–25.

Article  PubMed  PubMed Central  Google Scholar 

Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Yu Y, Sun Y, et al. SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a mendelian randomization study. Cardiovasc Diabetol. 2023;22(1):278.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun W, Wu X, Yang H, et al. Identifying causal associations between women’s reproductive traits and risk of schizophrenia: a multivariate validated two-sample mendelian randomization analysis. BMC Psychiatry. 2024;24(1):161.

Article  PubMed  PubMed Central  Google Scholar 

Khan MS, Fonarow GC, McGuire DK, et al. Glucagon-like peptide 1 receptor agonists and heart failure: the need for further evidence generation and practice guidelines optimization. Circulation. 2020;142(12):1205–18.